Article
Development of potent dual BET/HDAC inhibitors via pharmacophore merging and…
medRxiv · 2023 · Bauer, N.; Balourdas, D.-I.; Schneider, J. R.; Zhang, X.; Berger, L. M.; Berger, B.-T.; Klopp, N. A.; Siveke, J. T.; Knapp, S.; Joerger, A. C.
Key facts
| Title | Development of potent dual BET/HDAC inhibitors via pharmacophore merging and structure-guided optimization |
|---|---|
| First author | Bauer, N.; Balourdas, D.-I.; Schneider, J. R.; Zhang, X.; Berger, L. M.; Berger, B.-T.; Klopp, N. A.; Siveke, J. T.; Knapp, S.; Joerger, A. C. |
| Journal | medRxiv |
| Published | Jul 18, 2023 |
| DOI | 10.1101/2023.07.18.547334 |
| Devices mentioned | K103302 |
| Product codes mentioned | KIP, KIT, NDS, NJT, OOI |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1